Alcon, the eyecare division of Novartis, said it would investigate claims it used fake clinical trials to bribe doctors in China, the latest in what has become a steady stream of corruption allegations against mostly foreign pharmaceutical groups in the country.
诺华(Novartis)的眼科产品部门爱尔康(Alcon)表示，将调查有关其在manbetx3.0 利用假冒临床试验向医生行贿的指控。这是manbetx3.0 近期出现的一连串腐败指控的最新一例，其对象大多是在华经营的外资药企。
您已阅读10%（358字），剩余90%（3052字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。